Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 0
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Cetirizine hydrochloride | Cetirizine hydrochloride | tablet, oral | 37835-611ANDA |
Compare
Other companies listing cetirizine hydrochloride
- Granules Pharmaceuticals Inc.8 sites · 302 NDC
- Kenvue Brands LLC7 sites · 564 NDC
- Unichem Laboratories Limited, India5 sites · 272 NDC
- International Medication Systems, Ltd.3 sites · 2,801 NDC
- Padagis Israel Pharmaceuticals Ltd2 sites · 236 NDC
- AAA Pharmaceutical, Inc.2 sites · 26 NDC
- Preferred Pharmaceuticals Inc.1 site · 1,046 NDC
- NCS HealthCare of KY, LLC dba Vangard Labs1 site · 325 NDC
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.1 site · 273 NDC
- Strive Pharmaceuticals Inc.1 site · 35 NDC
Enquiry
Common questions
- Is Bi-Mar FDA approved?
- Bi-Mar holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Bi-Mar make?
- 1 product is listed under Bi-Mar in the openFDA NDC Directory, most often as tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.